Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia

Página do item simplificado
dc.creatorBou Khalil, Rami
dc.date.accessioned2020-07-03T13:34:09Z
dc.date.available2020-07-03T13:34:09Z
dc.date.issued2020-09
dc.description.abstractIndisponível.pt_BR
dc.identifier.citationBOU KHALIL, R. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia. Medical Hypotheses, [S.l.], v. 142, Sept. 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/41697
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0306987720309051pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceMedical Hypothesespt_BR
dc.subjectCOVID-19pt_BR
dc.subjectLithiumpt_BR
dc.subjectRapamycinpt_BR
dc.subjectCoronaviruspt_BR
dc.subjectMammalian target of rapamycin (mTOR)pt_BR
dc.titleLithium chloride combination with rapamycin for the treatment of COVID-19 pneumoniapt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)